CN103877140A - Application of saussurea involucrate culture in preparation of product for promoting bone health - Google Patents
Application of saussurea involucrate culture in preparation of product for promoting bone health Download PDFInfo
- Publication number
- CN103877140A CN103877140A CN201410136941.8A CN201410136941A CN103877140A CN 103877140 A CN103877140 A CN 103877140A CN 201410136941 A CN201410136941 A CN 201410136941A CN 103877140 A CN103877140 A CN 103877140A
- Authority
- CN
- China
- Prior art keywords
- bone
- culture
- bone health
- snow lotus
- saussurea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了雪莲培养物在制备促进骨骼健康产品中的应用,包括制备促进骨骼健康的食品或药品。所述促进骨骼健康为预防和治疗骨质疏松、提高骨钙含量、增加骨密度、改善类风湿关节炎和治疗关节炎。本发明通过动物试验和临床试验,发现雪莲培养物能够提高骨钙含量、增加骨密度以预防和治疗骨质疏松,能够改善类风湿关节炎,进而可以用于促进骨骼健康的食品和药品中。The invention discloses the application of snow lotus culture in preparing products for promoting bone health, including the preparation of food or medicine for promoting bone health. The promotion of bone health is prevention and treatment of osteoporosis, improvement of bone calcium content, increase of bone density, improvement of rheumatoid arthritis and treatment of arthritis. Through animal tests and clinical tests, the present invention finds that the snow lotus culture can increase bone calcium content, increase bone density to prevent and treat osteoporosis, improve rheumatoid arthritis, and can be used in food and medicine for promoting bone health.
Description
技术领域technical field
本发明涉及食品与医药技术领域,特别涉及雪莲培养物在制备促进骨骼健康产品中的应用。The invention relates to the technical fields of food and medicine, in particular to the application of snow lotus culture in preparing products for promoting bone health.
背景技术Background technique
骨质疏松症是一种以骨量低下,骨微结构损坏,导致骨脆性增加,易发生骨折为特征的全身性骨病。这是一种骨骼的退化性疾病,伴随年龄增长,患病风险增加。随着人类寿命延长和老龄化社会的到来,骨质疏松症已成为全人类的重要健康问题。骨质疏松症亦是威胁绝经期妇女的常见病和多发病。骨质疏松症由多种因素所致,它的基本病理机理是骨代谢过程中骨吸收和骨形成的偶联出现缺陷,导致人体内的钙磷代谢不平衡,使骨密度逐渐减少而引起的临床症状。骨质疏松症最常见的症症,以腰背痛多见,占疼痛患者中的70%~80%。疼痛沿脊柱向两侧扩散,仰卧或坐位时疼痛减轻,直立时后伸或久立、久坐时疼痛加剧,日间疼痛轻,夜间和清晨醒来时加重,弯腰、肌肉运动、咳嗽、大便用力时加重。Osteoporosis is a systemic bone disease characterized by low bone mass and damage to bone microarchitecture, resulting in increased bone fragility and susceptibility to fracture. It is a degenerative disease of the bones and the risk of developing it increases with age. With the extension of human life span and the arrival of aging society, osteoporosis has become an important health problem for all human beings. Osteoporosis is also a common and frequently-occurring disease that threatens menopausal women. Osteoporosis is caused by a variety of factors. Its basic pathological mechanism is the defect in the coupling of bone resorption and bone formation in the process of bone metabolism, which leads to the imbalance of calcium and phosphorus metabolism in the human body and the gradual decrease of bone density. Clinical symptoms. The most common symptom of osteoporosis is low back pain, accounting for 70% to 80% of pain patients. The pain spreads along the spine to both sides. The pain is relieved when lying on the back or sitting, and the pain is aggravated when standing upright or standing or sitting for a long time. The pain is mild during the day and aggravated at night and when waking up in the morning. Aggravated by straining to defecate.
骨钙即骨骼中钙元素的含量,骨钙含量减少是骨质疏松症的重要病理特征。骨密度全称是骨骼矿物质密度。骨密度的高低是衡量骨量多少的标准,反映骨质疏松的程度,预测骨折危险性的重要依据。提高骨骼中钙含量、增加骨密度,可以预防和治疗骨质疏松。Bone calcium is the content of calcium element in bones, and the reduction of bone calcium content is an important pathological feature of osteoporosis. The full name of bone density is bone mineral density. The level of bone mineral density is a measure of bone mass, reflects the degree of osteoporosis, and is an important basis for predicting the risk of fracture. Increasing the calcium content in bones and increasing bone density can prevent and treat osteoporosis.
类风湿性关节炎(RA)是一种以关节滑膜炎为特征的自身免疫性疾病,发病机制十分复杂,迄今尚未完全阐明。其临床表现为关节疼痛、肿胀、屈伸不利、晨僵等。在RA中,滑膜的持续性增生和软骨及骨的破坏是其重要的病理学特征。RA的动物模型有多种,弗氏完全佐剂诱导的大鼠关节炎是较为经典的模型之一。Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint synovitis. The pathogenesis is very complicated and has not been fully elucidated so far. Its clinical manifestations are joint pain, swelling, poor flexion and extension, and morning stiffness. In RA, the persistent hyperplasia of the synovium and the destruction of cartilage and bone are its important pathological features. There are many animal models of RA, and the rat arthritis induced by Freund's complete adjuvant is one of the more classic models.
雪莲培养物在提高骨钙含量、增加骨密度、预防和治疗骨质疏松方面的作用未见报道。The effects of Saussurea sauraceae culture on improving bone calcium content, increasing bone density, preventing and treating osteoporosis have not been reported.
ZL201210213551.7一种治疗骨质疏松症的中药药酒,记载了“以天山雪莲、西河柳、地枫皮、鹳草、仙茅补脾和胃,健脾益肺,强筋骨”,还记载了“天山雪莲用于风湿性关节炎,关节疼痛,肺寒咳嗽,肾与小腹冷痛,白带过多等”,并未记载雪莲或雪莲培养物具有增加骨密度、防治骨质疏松功效和相关药学数据。ZL201210213551.7 A traditional Chinese medicinal wine for the treatment of osteoporosis. It is recorded that "Tianshan snow lotus, Xihe willow, ground maple bark, stork grass, curculigo can invigorate the spleen and stomach, strengthen the spleen and lungs, and strengthen bones and muscles". "Tianshan Saussurea is used for rheumatoid arthritis, joint pain, lung cold cough, kidney and lower abdomen cold pain, excessive leucorrhea, etc.", there is no record that Saussurea or Saussurea culture can increase bone density, prevent and treat osteoporosis and related pharmaceuticals data.
发明申请201310299562.6一种治疗绝经妇女骨质疏松症的中药组合物,记载了雪莲花的传统功效,“主治雪肓、牙痛、风湿性关节炎、阳痿、月经不调、红崩、白带、胃溃疡、痔疮、支气管炎、心脏病、鼻出血和蛇咬伤等症,有通经活血,暧宫散淤、散寒除湿、强筋助阳、止血、消肿之功能”,也未记载雪莲或雪莲培养物增加骨密度、防止骨质疏松的功效和相关药学数据。Invention application 201310299562.6 A traditional Chinese medicine composition for the treatment of postmenopausal women with osteoporosis, records the traditional efficacy of snow lotus, "indications snow blindness, toothache, rheumatoid arthritis, impotence, irregular menstruation, red collapse, leucorrhea, gastric ulcer , hemorrhoids, bronchitis, heart disease, epistaxis and snake bites, etc., it has the functions of promoting menstruation and blood circulation, warming the uterus and dispelling stasis, dispelling cold and dehumidification, strengthening tendons and yang, stopping bleeding, and reducing swelling.” There is no record of snow lotus or Efficacy and related pharmaceutical data of Saussurea sauraceae culture in increasing bone density and preventing osteoporosis.
ZL200710017385.2具有增加骨密度功能的药物组合物及制备和质量控制方法,记载了“选用的中药骨碎补有补肾壮骨、强筋壮骨的功效,同时辅以具有抗骨质疏松活性的升麻,两者协同作用改善骨质增加骨密度”和“选用柠檬酸钙、珍珠粉和碳酸钙作为钙源,预防和缓解骨量丢失以防止骨折的发生,维持骨强度;同时补充酪蛋白磷酸肽促进人体对钙有较好的吸收”,并未记载雪莲或雪莲培养物具有增加骨密度、提高骨钙的功效和相关药学数据。ZL200710017385.2 has the function of increasing bone density and its preparation and quality control method. Cimicifuga, the two synergistically improve bone mass and increase bone density" and "Calcium citrate, pearl powder and calcium carbonate are selected as calcium sources to prevent and alleviate bone loss to prevent fractures and maintain bone strength; at the same time, supplement casein Phosphopeptides promote better absorption of calcium by the human body”, there is no record of Saussurea or Saussurea cultures having the effect of increasing bone density and bone calcium and related pharmaceutical data.
在抗关节炎方面,专利ZL201010519409.6披露了“雪莲培养物组合物通过实验发现,预防和缓解关节炎效果显著”,但该专利给出的雪莲培养物组合物含有以下组分:雪莲培养物、黄瓜籽粉、生菜籽粉、芹菜籽粉和、钙源,且雪莲培养物系为“弥补市面上菜籽类食品进行关节炎保健的单一性”而出现,未提及雪莲培养物在关节炎方面的独立作用。在抗炎效果的实施例中,采用的动物模型是醋酸引起小鼠腹腔毛细血管通透性变化以及角叉莱胶引致大鼠足拓肿胀,这仅仅能够说明上述组合物具有抗炎作用,而不能说明雪莲培养物在类风湿关节炎方面的作用。In terms of anti-arthritis, the patent ZL201010519409.6 discloses that "the snow lotus culture composition has been found through experiments to be effective in preventing and alleviating arthritis", but the snow lotus culture composition given in this patent contains the following components: Snow lotus culture , cucumber seed powder, lettuce seed powder, celery seed powder, and calcium source, and the culture of snow lotus appeared to "make up for the singleness of rapeseed food on the market for arthritis health care", and did not mention the culture of snow lotus Independent role in arthritis. In the embodiment of anti-inflammatory effect, the animal model adopted is that acetic acid causes changes in the permeability of mouse abdominal capillaries and carrageenan causes swelling of the paws of rats, which can only illustrate that the above-mentioned composition has anti-inflammatory effect, but The role of Saussurea cultures in rheumatoid arthritis cannot be stated.
发明内容Contents of the invention
本发明的目的是提出雪莲培养物在制备促进骨骼健康产品中的应用。The purpose of the present invention is to propose the application of the snow lotus culture in the preparation of products for promoting bone health.
雪莲培养物在制备促进骨骼健康产品中的应用。Application of snow lotus culture in preparation of products for promoting bone health.
本发明雪莲培养物是选取雪莲愈伤组织作为继代种子,通过细胞培养技术继代培养获得的,即中国专利ZL200510115902.0说明了雪莲培养物大规模培养的方法。The snow lotus culture of the present invention is obtained by selecting the snow lotus callus as the subculture seed and subcultured by cell culture technology, that is, the Chinese patent ZL200510115902.0 describes a method for large-scale culture of the snow lotus culture.
进一步地,本发明提供雪莲培养物在制备促进骨骼健康的食品或药品中的应用。Further, the present invention provides the application of Saussurea edulis culture in the preparation of food or medicine for promoting bone health.
进一步地,所述促进骨骼健康为预防和治疗骨质疏松。Further, the promotion of bone health is the prevention and treatment of osteoporosis.
进一步地,所述促进骨骼健康为提高骨钙含量。Further, the promotion of bone health is to increase bone calcium content.
进一步地,所述促进骨骼健康为增加骨密度。Further, the promotion of bone health is to increase bone density.
进一步地,所述促进骨骼健康为改善类风湿关节炎。Further, the promotion of bone health is improving rheumatoid arthritis.
进一步地,所述促进骨骼健康为治疗关节炎。Further, the promotion of bone health is the treatment of arthritis.
进一步地,所述药品的给药方式为口服、注射、输液或透皮给药。Further, the drug is administered in the form of oral administration, injection, infusion or transdermal administration.
进一步地,用雪莲培养物制备的食品服用量为每天0.02~4g(以雪莲培养物计),优选0.1~0.2g。Further, the dosage of the food prepared by the Saussurea chinensis culture is 0.02-4g (calculated by the Saussurea chinensis culture) per day, preferably 0.1-0.2g.
进一步地,用雪莲培养物制备的药品的服用量为每天0.02~12g(以雪莲培养物计)。Further, the dosage of the medicine prepared from the culture of snow lotus is 0.02-12 g per day (calculated based on the culture of snow lotus).
发明效果:Invention effect:
尽管治疗风湿性、类风湿性关节炎是雪莲的传统功效之一,但本发明的雪莲培养物是由天山雪莲通过植物细胞培养技术得到的(具体培养方法详见ZL200510115902.0),其颜色、性状与天山雪莲完全不同;功效成分组成与含量亦与天山雪莲大不相同,雪莲培养物中黄酮、多糖、绿原酸、紫丁香甙的含量均远远高于野生的天山雪莲。可以认为,雪莲培养物虽来源于天山雪莲,但与天山雪莲又完全不同。Although the treatment of rheumatism and rheumatoid arthritis is one of the traditional efficacy of Saussurea involucrata, the culture of Saussurea involucrata in the present invention is obtained from Tianshan Saussurea indica through plant cell culture technology (see ZL200510115902.0 for specific cultivation methods), its color, The traits are completely different from Tianshan Saussurea; the composition and content of functional components are also very different from Tianshan Saussurea, the content of flavonoids, polysaccharides, chlorogenic acid, and syringin in the culture of Saussurea chinensis are much higher than that of wild Tianshan Saussurea. It can be considered that although the culture of snow lotus comes from Tianshan snow lotus, it is completely different from Tianshan snow lotus.
本发明通过动物试验和临床试验,发现雪莲培养物能够提高骨钙含量、增加骨密度以预防和治疗骨质疏松,能够改善类风湿关节炎,进而可以用于促进骨骼健康的食品和药品中。Through animal tests and clinical tests, the present invention finds that the snow lotus culture can increase bone calcium content, increase bone density to prevent and treat osteoporosis, improve rheumatoid arthritis, and can be used in food and medicine for promoting bone health.
具体实施方式Detailed ways
下述非限制性实施例可以使本领域的普通技术人员更全面地理解本发明,但不以任何方式限制本发明。The following non-limiting examples can enable those skilled in the art to understand the present invention more fully, but do not limit the present invention in any way.
实施例1Example 1
BMD(骨密度)是骨科临床常用生理指标,为目前诊断骨质疏松症的标准。世界卫生组织对于骨质疏松的定义是基于骨密度的T值(将检查所得到骨密度(BMD)与正常年轻人群的BMD相比,以得出高出(+)或低于(-)年轻人的标准差(SD)数),具体如下:BMD (Bone Mineral Density) is a commonly used physiological index in orthopedic clinics, and is currently the standard for diagnosing osteoporosis. The World Health Organization's definition of osteoporosis is based on the T value of bone density (comparing the bone density (BMD) obtained by the examination with the BMD of the normal young population to obtain a high (+) or low (-) young age The standard deviation (SD) number of people), as follows:
正常:骨密度在年轻人平均值的1SD内(T值介于+1~-1);Normal: bone mineral density within 1 SD of the mean for young people (T value between +1 and -1);
低骨密度:骨密度低于年轻人的平均值1~2.5SD(T值介于-1~-2.5);Low bone density: the bone density is 1-2.5 SD lower than the average value of young people (T value is between -1 and -2.5);
骨质疏松症:骨密度低于年轻人的平均值2.5SD(T值低于-2.5);Osteoporosis: bone mineral density 2.5 SD lower than the mean for young people (T value lower than -2.5);
严重骨质疏松症:骨密度低于年轻人的平均值2.5SD(T值低于-2.5),伴有一处或多处骨质疏松性骨折。Severe osteoporosis: Bone mineral density 2.5 SD below the mean for young adults (T-score below -2.5) with one or more osteoporotic fractures.
样品:雪莲培养物胶囊,每粒含雪莲培养物粉末100mg;Sample: snow lotus culture capsules, each containing 100mg of snow lotus culture powder;
服用量:每日两粒;Dosage: two capsules per day;
服用时间:6个月;Taking time: 6 months;
骨密度测量仪:双能X线骨密度仪Bone Densitometer: Dual Energy X-ray Densitometer
测量部位:桡骨远端Measurement site: distal radius
实施例2Example 2
雪莲培养物用于类风湿关节炎临床试验Saussurea cerevisiae culture used in clinical trials of rheumatoid arthritis
试验方法:病例选择参考美国风湿病学会类风湿关节炎诊断标准,病程6个月-11年,服用雪莲培养物后,观察患者体征情况。Test method: Case selection refers to the diagnostic criteria of rheumatoid arthritis of the American College of Rheumatology. The course of disease is 6 months to 11 years.
病例数量:15Number of cases: 15
试验时间:4周Trial time: 4 weeks
服用剂量:每日2次,每次100mg雪莲培养物Dosage: 2 times a day, 100mg sausage culture each time
试验结果:疼痛改善73.3%,肿胀改善66.7%,晨僵改善60.0%。Test results: Pain improved by 73.3%, swelling improved by 66.7%, and morning stiffness improved by 60.0%.
治疗后患者关节疼痛、肿胀、晨僵总效果比较Comparison of the total effect of joint pain, swelling and morning stiffness in patients after treatment
实验例1Experimental example 1
雪莲培养物增加骨密度、提高骨钙含量,防治骨质疏松的药效实验Drug efficacy experiment of Saussurea edulis culture in increasing bone density, increasing bone calcium content, and preventing and treating osteoporosis
材料与方法Materials and Methods
试验分组:假手术组、模型对照组、阳性对照组(雌二醇0.12mg/kg)Test grouping: sham operation group, model control group, positive control group (estradiol 0.12mg/kg)
试验模型:去卵巢骨密度低下模型Test model: ovariectomized low bone density model
试验动物:SD成年雌性大鼠,去势手术前适应饲养3-5天。Experimental animals: SD adult female rats, adapted to feeding for 3-5 days before castration.
造模方法:大鼠行双侧卵巢切除术去势,同时给与特殊饲料,造成骨密度低下模型;另取部分大鼠行类似手术但不切除双侧卵巢,仅摘除部分脂肪,即为假手术组。Modeling method: Rats underwent bilateral ovariectomy to castrate, and at the same time were given special feed to form a model with low bone density; another part of the rats underwent similar operations but did not remove bilateral ovaries, only part of the fat was removed, which was a sham model. surgery group.
配方饲料参照AIN93饲料配方配制半成品饲料,用适当物质替换饲料中来源于大豆的成分,以避免大豆异黄酮等植物激素对实验结果的干扰。配方组成:酪蛋白23%,DL-蛋氨酸0.3%,玉米淀粉32%,蔗糖30%,纤维5%,玉米油5%,混合矿物盐3.5%,混合维生素1%,二酒石酸胆碱0.2%,北京科澳协力饲料有限公司生产。The formula feed was formulated with reference to the AIN93 feed formula to prepare the semi-finished feed, and the soybean-derived ingredients in the feed were replaced with appropriate substances to avoid the interference of soybean isoflavones and other plant hormones on the experimental results. Formula composition: casein 23%, DL-methionine 0.3%, corn starch 32%, sucrose 30%, fiber 5%, corn oil 5%, mixed mineral salt 3.5%, mixed vitamin 1%, choline bitartrate 0.2%, Produced by Beijing Keao Xieli Feed Co., Ltd.
雪莲培养物高剂量组(100mg/kg.d)、雪莲培养物中剂量组(33.3mg/kg.d)、雪莲培养物低剂量组(16.7mg/kg.d)本发明所述mg/kg.d即每千克大鼠体重的日给药量。Snow lotus culture high-dose group (100mg/kg.d), snow lotus culture medium-dose group (33.3mg/kg.d), snow lotus culture low-dose group (16.7mg/kg.d) mg/kg of the present invention .d is the daily dose per kilogram of rat body weight.
动物数量:每组12只Number of animals: 12 per group
给药方法:经口灌胃给药,每天1次,持续3个月。Administration method: Oral gavage administration, once a day, for 3 months.
检测项目:三个月后,取大鼠股骨,测定骨钙、骨密度(股骨中点和股骨远心端)、灰重和干重等。Test items: Three months later, the rat femur was taken to measure bone calcium, bone density (midpoint of femur and distal end of femur), ash weight and dry weight.
骨钙测定:原子吸收法测定骨钙含量;Determination of bone calcium: determination of bone calcium content by atomic absorption method;
骨密度测定:用骨密度仪测定股骨中点和股骨远心端密度。Bone Densitometry: Measure the density of the midpoint of the femur and the distal end of the femur with a bone densitometer.
雪莲培养物对卵巢切除大鼠骨钙和骨密度的影响Effects of Snow Lotus Culture on Bone Calcium and Bone Density in Ovariectomized Rats
注:与模型组比较,*p<0.05,**p<0.01,***p<0.001。Note: Compared with the model group, *p<0.05, **p<0.01, ***p<0.001.
结果:卵巢切除后,模型组与假手术组相比,大鼠骨密度和骨钙含量均有明显降低并具有统计学意义,说明去除卵巢大鼠由于雌激素缺乏可以造成大鼠骨钙和骨密度降低,造模成功;给药90天后,雪莲培养物各剂量组的骨钙含量较模型组均有明显升高,并有统计学意义(p<0.01或p<0.001);股骨远端骨密度与模型组相比都有明显提高,具有显著性差异(p<0.05或p<0.01);股骨中点骨密度各个剂量组也有不同程度增加,低剂量组与模型组相比具有显著性差异(p<0.05)。Results: After ovariectomy, compared with the sham operation group, the bone mineral density and bone calcium content of the rats in the model group were significantly reduced and had statistical significance, indicating that ovariectomized rats can cause bone calcium and The density decreased, and the modeling was successful; after 90 days of administration, the bone calcium content of each dose group of Saussurea chinensis culture was significantly higher than that of the model group, and there was statistical significance (p<0.01 or p<0.001); the bone of distal femur Compared with the model group, the density was significantly improved, with a significant difference (p<0.05 or p<0.01); the bone density of the midpoint of the femur also increased to varying degrees in each dose group, and the low-dose group had a significant difference compared with the model group (p<0.05).
结论:雪莲培养物对于骨密度低下模型大鼠有明显的增加骨钙的作用,对于股骨中点骨密度和股骨远端骨密度也有增加作用。因此,雪莲培养物可以用于预防和治疗骨质疏松,促进骨骼健康。Conclusion: Saussurea sauraceae culture can significantly increase bone calcium in rats with low bone density, and can also increase bone density at the midpoint of the femur and at the distal end of the femur. Therefore, the culture of snow lotus can be used to prevent and treat osteoporosis and promote bone health.
实验例2Experimental example 2
弗氏完全佐剂大鼠关节炎模型是类风湿关节炎的常用动物模型之一。本实验例旨在说明雪莲培养物对大鼠佐剂关节炎的治疗作用,进而说明其对类风湿关节炎的治疗作用。材料与方法Rat arthritis model in complete Freund's adjuvant is one of the commonly used animal models for rheumatoid arthritis. The purpose of this experiment is to illustrate the therapeutic effect of Saussurea sauraceae culture on adjuvant arthritis in rats, and further illustrate its therapeutic effect on rheumatoid arthritis. Materials and Methods
试验分组:溶媒组(0.5%羧甲基纤维素钠)、阳性对照组(旭痹颗粒2g/kg、吲哚美辛4.5mg/kg)、雪莲培养物高剂量组(140mg/kg.d)、雪莲培养物中剂量组(70mg/kg.d)、雪莲培养物低剂量组(35mg/kg.d)Test groups: vehicle group (0.5% sodium carboxymethyl cellulose), positive control group (Xubi granule 2g/kg, indomethacin 4.5mg/kg), high-dose snow lotus culture group (140mg/kg.d) , medium dose group of Saussurea indica culture (70mg/kg.d), low dose group of Saussurea indica culture (35mg/kg.d)
试验模型:弗氏完全佐剂大鼠关节炎模型Experimental model: Rat arthritis model in complete Freund's adjuvant
试验动物:体重160-200g的大鼠,雌雄各半。Test animals: rats with a body weight of 160-200 g, half male and half male.
造模方法:用足容积测定仪分别测定大鼠两侧后肢足容积,右后足跖皮下注射弗氏完全佐剂(含灭活结核杆菌0.5毫克)0.1ml,注射后第15天测定动物体重,两侧后肢足容积,以左侧(非致炎足)后肢肿胀率和体重分组,分为六组,每组10只。Modeling method: Use a foot volume measuring instrument to measure the volume of the hind limbs on both sides of the rat, inject 0.1ml of Freund's complete adjuvant (containing 0.5 mg of inactivated Mycobacterium tuberculosis) subcutaneously into the right hind foot, and measure the animal's weight on the 15th day after injection , the volume of the hindlimbs on both sides, and the swelling rate and body weight of the left (non-inflammatory feet) hindlimbs were divided into six groups, with 10 rats in each group.
动物数量:每组10只Number of animals: 10 per group
给药方法:灌胃给药,给药容积均为20ml/kg。每日一次,给予七天。Administration method: intragastric administration, the administration volume is 20ml/kg. Once daily, give for seven days.
检测项目和方法:分别在给药后的第2、5、8天测定每只动物的体重,两侧后肢足容积,计算出左右足跖肿胀率。Test items and methods: The body weight of each animal and the volume of both hind limbs were measured on the 2nd, 5th, and 8th days after administration, and the swelling rate of the left and right paws was calculated.
雪莲培养物对佐剂关节炎大鼠致炎足足跖肿胀的影响Effects of Snow Lotus Culture on Inflamed Paw and Plantar Swelling in Rats with Adjuvant Arthritis
注:与溶媒组比较,*p<0.05,Student’s-t检验Note: Compared with the vehicle group, *p<0.05, Student’s-t test
结果表明,治疗性给予雪莲组织细胞培养物后,第5、8天雪莲组织细胞培养物对致炎足足跖肿胀可见一定的抑制作用。The results showed that after the curative administration of the Saussurea sativa tissue cell culture, the 5th and 8th day, the Saussurea sauraceae tissue cell culture had a certain inhibitory effect on the inflammatory paw swelling.
雪莲培养物对佐剂关节炎大鼠非致炎足足跖肿胀的影响Effects of Snow Lotus Culture on Paw Swelling of Non-inflammatory Rats with Adjuvant Arthritis
注:与溶媒组比较,*p<0.05,**p<0.01,Student’s-t检验Note: Compared with vehicle group, *p<0.05, **p<0.01, Student’s-t test
结果表明,70mg/kg、140mg/kg的雪莲组织细胞培养物给药后第5、8天对非致炎足因迟发型超敏反应引起的肿胀有显著的抑制作用。The results showed that the 70mg/kg and 140mg/kg Saussurea tissue cell culture had a significant inhibitory effect on the swelling of non-inflammatory feet caused by delayed hypersensitivity on the 5th and 8th day after administration.
结论:治疗性给予雪莲组织细胞培养物质,70mg/kg、140mg/kg的雪莲组织细胞培养物在第5、8天对佐剂关节炎大鼠致炎足肿胀率有一定抑制作用,但没有统计学意义;面对另侧反肢(非致炎足)因迟发超敏反应引起的足肿胀有显著的抑制作用。Conclusion: Therapeutic administration of Saussurea edulis tissue cell culture substances, 70mg/kg, 140mg/kg of Saussurea edulis tissue cell culture has a certain inhibitory effect on the inflammatory foot swelling rate of rats with adjuvant arthritis on the 5th and 8th day, but there is no statistics It has significant inhibitory effect on paw swelling caused by delayed hypersensitivity reaction in the face of the other antilimb (non-inflammatory foot).
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410136941.8A CN103877140A (en) | 2014-04-04 | 2014-04-04 | Application of saussurea involucrate culture in preparation of product for promoting bone health |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410136941.8A CN103877140A (en) | 2014-04-04 | 2014-04-04 | Application of saussurea involucrate culture in preparation of product for promoting bone health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103877140A true CN103877140A (en) | 2014-06-25 |
Family
ID=50946476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410136941.8A Pending CN103877140A (en) | 2014-04-04 | 2014-04-04 | Application of saussurea involucrate culture in preparation of product for promoting bone health |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103877140A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104839737A (en) * | 2015-04-22 | 2015-08-19 | 云南尚源生物科技有限公司 | Sport nutrition food |
| CN106260359A (en) * | 2016-09-18 | 2017-01-04 | 大连普瑞康生物技术有限公司 | A kind of Saussurea involucrata culture compositions Ganoderma tea and preparation method thereof |
| CN106360390A (en) * | 2016-10-26 | 2017-02-01 | 广州莱可福生物科技有限公司 | Dietary supplements capable of enhancing bone density and preventing and improving osteoarthritis and production method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101904887A (en) * | 2010-07-13 | 2010-12-08 | 大连普瑞康生物技术有限公司 | Application of Snow Lotus Culture in Food and Anti-inflammatory and Analgesic Drugs |
| CN102366432A (en) * | 2011-11-02 | 2012-03-07 | 大连普瑞康生物技术有限公司 | Saussurea involucrata culture extract and novel purpose thereof |
| CN102450647A (en) * | 2010-10-26 | 2012-05-16 | 天津天狮生物发展有限公司 | Saussurea involucrate culture composition for preventing and relieving arthritis |
| CN103238841A (en) * | 2013-05-23 | 2013-08-14 | 昆明宝特药用植物研究开发有限公司 | Food composition containing Maca and saussurea involucrata culture and application thereof |
| CN103330837A (en) * | 2013-07-17 | 2013-10-02 | 王磊 | Traditional Chinese medicine composition for curing osteoporosis of menopausal women |
-
2014
- 2014-04-04 CN CN201410136941.8A patent/CN103877140A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101904887A (en) * | 2010-07-13 | 2010-12-08 | 大连普瑞康生物技术有限公司 | Application of Snow Lotus Culture in Food and Anti-inflammatory and Analgesic Drugs |
| CN102450647A (en) * | 2010-10-26 | 2012-05-16 | 天津天狮生物发展有限公司 | Saussurea involucrate culture composition for preventing and relieving arthritis |
| CN102366432A (en) * | 2011-11-02 | 2012-03-07 | 大连普瑞康生物技术有限公司 | Saussurea involucrata culture extract and novel purpose thereof |
| CN103238841A (en) * | 2013-05-23 | 2013-08-14 | 昆明宝特药用植物研究开发有限公司 | Food composition containing Maca and saussurea involucrata culture and application thereof |
| CN103330837A (en) * | 2013-07-17 | 2013-10-02 | 王磊 | Traditional Chinese medicine composition for curing osteoporosis of menopausal women |
Non-Patent Citations (2)
| Title |
|---|
| 欧阳荣等主编: "《临床常用中药饮片原色图谱》", 31 October 2013 * |
| 马勇等编著: "《骨质疏松症患者吃什么》", 31 October 2000 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104839737A (en) * | 2015-04-22 | 2015-08-19 | 云南尚源生物科技有限公司 | Sport nutrition food |
| CN106260359A (en) * | 2016-09-18 | 2017-01-04 | 大连普瑞康生物技术有限公司 | A kind of Saussurea involucrata culture compositions Ganoderma tea and preparation method thereof |
| CN106360390A (en) * | 2016-10-26 | 2017-02-01 | 广州莱可福生物科技有限公司 | Dietary supplements capable of enhancing bone density and preventing and improving osteoarthritis and production method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103230574B (en) | Traditional Chinese medical composition for treating porcine epizootic diarrhea and application thereof | |
| CN103877140A (en) | Application of saussurea involucrate culture in preparation of product for promoting bone health | |
| BR112017015340B1 (en) | USE OF TAURINE IN THE PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY VIRUS OF THE CORONAVIRUS GENDER AND/OR ROTAVIRUS GENDER | |
| CN102698158A (en) | Traditional Chinese medicine for preventing and treating infectious bronchitis, preparation method thereof and feed | |
| CN106620604A (en) | Navel moxibustion traditional Chinese medicine composition for treating chronic diarrhea as well as preparation method and application thereof | |
| CN101396427A (en) | Traditional Chinese medicine oral liquid for treating poultry virus hepatitis and hepatic injury | |
| CN105194676B (en) | A kind of pharmaceutical composition for treating hyperlipidemia and preparation method thereof | |
| CN105106533B (en) | A kind of Chinese medicine composition for treating gestational period gall stone | |
| CN104771734B (en) | A kind of Chinese medicine composition for treating chronic cardiopulmonary disease | |
| CN104324319A (en) | Health-caring product promoting health of bone joint | |
| CN103599094B (en) | Application of 4-oxopentanoic acid in preparation of antidiarrheal medicines | |
| CN115251339B (en) | Functional food composition for increasing bone density by regulating intestinal flora and preparation method thereof | |
| RU2076731C1 (en) | Agent and method of organism nonspecific resistance increase at viscera morbidity | |
| CN104689176B (en) | A kind of Chinese medicine preparation for treating knee osteoarthritis and preparation method thereof | |
| CN105832714B (en) | Application of taurine in preventing and/or treating diseases caused by coronavirus and/or rotavirus viruses | |
| CN107982409B (en) | Traditional Chinese medicine composition and pill for treating syringomyelia and preparation method thereof | |
| CN106377659A (en) | Traditional Chinese medicine pulvis used for preventing and treating fever diseases of livestock and poultry | |
| CN106138960A (en) | Medical composition and its use | |
| CN103432394B (en) | A kind of Chinese medicine treating systemic sclerosis | |
| CN106309989A (en) | Drug for treating uremia and complication thereof | |
| CN117959375A (en) | A Chinese medicine composition for warming muscles and removing cold and dampness between meridians | |
| CN103623378B (en) | Traditional Chinese medicine for treating thoraco-abdominal aorta type polyarteritis | |
| CN103495038A (en) | Traditional Chinese medicine formula treating gastroenteric ulcers | |
| CN102641472B (en) | Chinese herbal preparation for curing osteoporosis | |
| CN118903273A (en) | Traditional Chinese medicine nursing agent for increasing bone mineral density and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140625 |


